BamSEC and AlphaSense Join Forces
Learn More

Evoke Pharma Inc.

NASDAQ: EVOK    
Share price (1/6/25): $4.60    
Market cap (1/6/25): $6.836 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1
from SC 13G/A 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.1
from 8-K 42 pages Underwriting Agreement Between Evoke Pharma, Inc. and Craig-Hallum Capital Group LLC Laidlaw & Company (Uk) Ltd. as Representatives of the Several Underwriters Evoke Pharma, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 42 pages Underwriting Agreement Between Evoke Pharma, Inc. and Craig-Hallum Capital Group LLC Laidlaw & Company (Uk) Ltd. as Representatives of the Several Underwriters
12/34/56
EX-1.1
from S-1/A 43 pages Underwriting Agreement Between Evoke Pharma, Inc. and Craig-Hallum Capital Group LLC Laidlaw & Company (Uk) Ltd. as Representatives of the Several Underwriters Evoke Pharma, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 26 pages 5,000,000 Shares Evoke Pharma, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.2
from S-3 46 pages Evoke Pharma, Inc. Common Stock (Par Value $0.0001 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-1
from SC 13G 1 page Joint Filing Agreement
12/34/56
EX-1.3
from S-3 4 pages Amendment No. 1 to at Market Issuance Sales Agreement
12/34/56
EX-1.1
from 8-K 27 pages 2,413,793 Shares Evoke Pharma, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.2
from S-3 38 pages Evoke Pharma, Inc. Common Stock (Par Value $0.0001 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-1.1
from S-1/A 62 pages Underwriting Agreement Between Evoke Pharma, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Evoke Pharma, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 63 pages Underwriting Agreement Between Evoke Pharma, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Evoke Pharma, Inc. Underwriting Agreement
12/34/56